Neuroendocrine tumours-challenges in the diagnosis and classification of pulmonary neuroendocrine tumours

Journal of Clinical Pathology

Volumn 66, Issue 10, 2013, Pages 862-869

  Den Bakker, M A ^a,b   Thunnissen, F B J M ^c  

^a Maasstad Hospital Rotterdam   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMOGRANIN; CYTOKERATIN; DESMIN; EPITHELIAL MEMBRANE ANTIGEN; THYROID TRANSCRIPTION FACTOR 1; TRANSCRIPTION FACTOR CDX2; VIMENTIN;

BRONCHIOLITIS OBLITERANS; BRONCHUS CARCINOID; CANCER DIAGNOSIS; CANCER PATIENT; CANCER PROGNOSIS; CELL DIFFERENTIATION; CELL PROLIFERATION; CYTOLOGY; DESMOPLASTIC SMALL ROUND CELL TUMOR; DIFFERENTIAL DIAGNOSIS; DIFFUSE IDIOPATHIC PULMONARY NEUROENDOCRINE CELL HYPERPLASIA; DISEASE SEVERITY; DYSPNEA; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LARGE CELL NEUROENDOCRINE CARCINOMA; LUNG BIOPSY; LUNG DISEASE; LUNG RESECTION; LUNG SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; LUNG TRANSPLANTATION; LUNG TUMOR; MEMBRANE; MITOSIS RATE; NEUROENDOCRINE TUMOR; PRIORITY JOURNAL; PULMONARY DESMOPLASTIC SMALL ROUND CELL TUMOR; PULMONARY NEUROENDOCRINE TUMOR; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; RISK FACTOR; SURVIVAL RATE; SYMPTOM; TUMOR CELL; TUMOR CLASSIFICATION; TUMOR GROWTH; TUMOR VOLUME;

HISTOPATHOLOGY; LUNG; NEUROENDOCRINE;

CARCINOID TUMOR; CARCINOMA, LARGE CELL; CELL PROLIFERATION; DIAGNOSIS, DIFFERENTIAL; HUMANS; LUNG; LUNG NEOPLASMS; NEUROENDOCRINE TUMORS; PROGNOSIS; SMALL CELL LUNG CARCINOMA;

EID: 84884979038     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jclinpath-2012-201310     Document Type: Review

References (67)

1. Howe MC, Chapman A, Kerr K, et al. Neuroendocrine differentiation in non-small cell lung cancer and its relation to prognosis and therapy. Histopathology 2005.;46:195-201. (Pubitemid 40293018)
2. Gosney JR, Gosney MA, Lye M, et al. Reliability of commercially available immunocytochemical markers for identification of neuroendocrine differentiation in bronchoscopic biopsies of bronchial carcinoma. Thorax 1995;50:116-20.
3. Ionescu DN, Treaba D, Gilks CB, et al. Nonsmall cell lung carcinoma with neuroendocrine differentiation-an entity of no clinical or prognostic significance. Am J Surg Pathol 2007;31:26-32. (Pubitemid 46036899)
4. Warren WH, Hammar SP. The dispersed neuroendocrine system, its bronchopulmonary elements, and neuroendocrine tumors presumed to be derived from them: myths, mistaken notions, and misunderstandings. Semin Thorac Cardiovasc Surg 2006;18:178-82. (Pubitemid 44914570)
5. Boers JE, den Brok JL, Koudstaal J, et al. Number and proliferation of neuroendocrine cells in normal human airway epithelium. Am J Respir Crit Care Med 1996;154:758-63. (Pubitemid 26327302)
6. Bennet G, Chew F. Pulmonary carcinoid tumorlets. Am J Roentgenol 1994;162:568. (Pubitemid 24093555)
7. Mukhopadhyay S, El-Zammar OA, Katzenstein AL. Pulmonary meningothelial-like nodules: new insights into a common but poorly understood entity. Am J Surg Pathol 2009;33:487-95.
8. Gaffey MJ, Mills SE, Askin FB. Minute pulmonary meningothelial-like nodules. A clinicopathologic study of so-called minute pulmonary chemodectoma. Am J Surg Pathol 1988;12:167-75. (Pubitemid 18085200)
9. Suster S, Moran CA. Diffuse pulmonary meningotheliomatosis. Am J Surg Pathol 2007.;31:624-31. (Pubitemid 46569048)
10. Aguayo SM, Miller YE, Waldron JA Jr, et al. Brief report: idiopathic diffuse hyperplasia of pulmonary neuroendocrine cells and airways disease. N Engl J Med 1992.;327:1285-8.
11. Miller MA, Mark GJ, Kanarek D. Multiple peripheral pulmonary carcinoids and tumorlets of carcinoid type, with restrictive and obstructive lung disease. Am J Med 1978.;65:373-8. (Pubitemid 9003383)
12. Davies SJ, Gosney JR, Hansell DM, et al. Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: an under-recognised spectrum of disease. Thorax 2007;62:248-52. (Pubitemid 46579807)
13. Gorshtein A, Gross DJ, Barak D, et al. Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia and the associated lung neuroendocrine tumors: clinical experience with a rare entity. Cancer 2012;118:612-19.
14. Nassar AA, Jaroszewski DE, Helmers RA, et al. Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: a systematic overview. Am J Respir Crit Care Med 2011.;184:8-16.
15. Hage R, de la Riviere AB, Seldenrijk CA, et al. Update in pulmonary carcinoid tumors: a review article. Ann Surg Oncol 2003;10:697-704. (Pubitemid 40486903)
16. Flieder DB. Neuroendocrine tumors of the lung: recent developments in histopathology. Curr Opin Pulm Med 2002;8:275-80. (Pubitemid 34625960)
17. Travis WD, Gal AA, Colby TV, et al. Reproducibility of neuroendocrine lung tumor classification. Hum Pathol 1998;29:272-9. (Pubitemid 28123925)
18. Swarts DR, Henfling ME, Van Neste L, et al. CD44 and OTP are strong prognostic markers for pulmonary carcinoids. Clin Cancer Res 2013;19:2197-2207.
19. Morandi U, Casali C, Rossi G. Bronchial typical carcinoid tumors. Semin Thorac Cardiovasc Surg 2006;18:191-8. (Pubitemid 44914572)
20. Debelenko LV, Brambilla E, Agarwal SK, et al. Identification of MEN1 gene mutations in sporadic carcinoid tumors of the lung. Hum Mol Genet 1997.;6:2285-90. (Pubitemid 27501081)
21. Trump D, Farren B, Wooding C, et al. Clinical studies of multiple endocrine neoplasia type 1 (MEN1). QJM 1996;89:653-69. (Pubitemid 26319017)
22. Oliveira AM, Tazelaar HD, Myers JL, et al. Thyroid transcription factor-1 distinguishes metastatic pulmonary from well-differentiated neuroendocrine tumors of other sites. Am J Surg Pathol 2001;25:815-19. (Pubitemid 32496873)
23. Saqi A, Alexis D, Remotti F, et al. Usefulness of CDX2 and TTF-1 in Differentiating Gastrointestinal From Pulmonary Carcinoids. Am J Clin Pathol 2005;123:394-404. (Pubitemid 40315081)
24. Du EZ, Goldstraw P, Zacharias J, et al. TTF-1 expression is specific for lung primary in typical and atypical carcinoids: TTF-1-positive carcinoids are predominantly in peripheral location. Hum Pathol 2004;35:825-31. (Pubitemid 38903075)
25. La Rosa S, Chiaravalli AM, Placidi C, et al. TTF1 expression in normal lung neuroendocrine cells and related tumors: immunohistochemical study comparing two different monoclonal antibodies. Virchows Arch 2010;457:497-507.
26. Pelosi G, Rodriguez J, Viale G, et al. Typical and atypical pulmonary carcinoid tumor overdiagnosed as small-cell carcinoma on biopsy specimens: a major pitfall in the management of lung cancer patients. Am J Surg Pathol 2005;29:179-87. (Pubitemid 40170635)
27. Erickson D, Kudva YC, Ebersold MJ, et al. Benign paragangliomas: clinical presentation and treatment outcomes in 236 patients. J Clin Endocrinol Metab 2001.;86:5210-16. (Pubitemid 33070237)
28. Shibahara J, Goto A, Niki T, et al. Primary pulmonary paraganglioma: report of a functioning case with immunohistochemical and ultrastructural study. Am J Surg Pathol 2004;28:825-9. (Pubitemid 38685899)
29. Skodt V, Jacobsen GK, Helsted M. Primary paraganglioma of the lung. Report of two cases and review of the literature. APMIS 1995;103:597-603.
30. Resl M, Kral B, Simek J, et al. S-100 protein positive (sustentacular) cells in pulmonary carcinoid tumorlets: a quantitative study of 24 cases. Pathol Res Pract 1996.;192:414-17. (Pubitemid 26232216)
31. Santambrogio L, Nosotti M, Palleschi A, et al. Primary pulmonary glomangioma: a coin lesion negative on PET study. Case report and literature review. Thorac Cardiovasc Surg 2011;59:380-2.
32. Ordonez NG. Value of thyroid transcription factor-1 immunostaining in distinguishing small cell lung carcinomas from other small cell carcinomas. Am J Surg Pathol 2000;24:1217-23.
33. Agoff SN, Lamps LW, Philip AT, et al. Thyroid transcription factor-1 is expressed in extrapulmonary small cell carcinomas but not in other extrapulmonary neuroendocrine tumors. Mod Pathol 2000;13:238-42. (Pubitemid 30207508)
34. Kaufmann O, Dietel M. Expression of thyroid transcription factor-1 in pulmonary and extrapulmonary small cell carcinomas and other neuroendocrine carcinomas of various primary sites. Histopathology 2000;36:415-20. (Pubitemid 30311623)
35. Nicholson SA, Beasley MB, Brambilla E, et al. Small cell lung carcinoma (SCLC): a clinicopathologic study of 100 cases with surgical specimens. Am J Surg Pathol 2002.;26:1184-97. (Pubitemid 34969188)
36. Wu M, Wang B, Gil J, et al. p63 and TTF-1 immunostaining. A useful marker panel for distinguishing small cell carcinoma of lung from poorly differentiated squamous cell carcinoma of lung. Am J Clin Pathol 2003;119:696-702. (Pubitemid 37051496)
37. Renshaw AA, Voytek TM, Haja J, et al. Distinguishing small cell carcinoma from non-small cell carcinoma of the lung: correlating cytologic features and performance in the College of American Pathologists Non-Gynecologic Cytology Program. Arch Pathol Lab Med 2005;129:619-23. (Pubitemid 40616964)
38. van Riel S, Thunnissen E, Heideman D, et al. A patient with simultaneously appearing adenocarcinoma and small-cell lung carcinoma harbouring an identical EGFR exon 19 mutation. Ann Oncol 2012;23:3188-9.
39. Travis W, Brambilla E, Müller-Hermelink H, et al. Pathology and genetics of tumours of the lung, pleura, thymus and heart. Lyon: IARC Press, 2004.
40. Travis WD, Linnoila RI, Tsokos MG, et al. Neuroendocrine tumors of the lung with proposed criteria for large-cell neuroendocrine carcinoma. An ultrastructural, immunohistochemical, and flow cytometric study of 35 cases. Am J Surg Pathol 1991.;15:529-53.
41. Marchevsky AM, Gal AA, Shah S, et al. Morphometry confirms the presence of considerable nuclear size overlap between small cells and large cells in high-grade pulmonary neuroendocrine neoplasms. Am J Clin Pathol 2001;116:466-72. (Pubitemid 34450278)
42. Vollmer RT. The effect of cell size on the pathologic diagnosis of small and large cell carcinomas of the lung. Cancer 1982;50:1380-3. (Pubitemid 12031963)
43. Ha SY, Han J, Kim WS, et al. Interobserver variability in diagnosing high-grade neuroendocrine carcinoma of the lung and comparing it with the morphometric analysis. Korean J Pathol 2012;46:42-7.
44. den Bakker MA, Willemsen S, Grunberg K, et al. Small cell carcinoma of the lung and large cell neuroendocrine carcinoma interobserver variability. Histopathology 2010;56:356-63.
45. Takei H, Asamura H, Maeshima A, et al. Large cell neuroendocrine carcinoma of the lung: a clinicopathologic study of eighty-seven cases. J Thorac Cardiovasc Surg 2002.;124:285-92. (Pubitemid 35025604)
46. Sun JM, Ahn MJ, Ahn JS, et al. Chemotherapy for pulmonary large cell neuroendocrine carcinoma: similar to that for small cell lung cancer or non-small cell lung cancer? Lung Cancer 2012;77:365-70.
47. Sun L, Sakurai S, Sano T, et al. High-grade neuroendocrine carcinoma of the lung: comparative clinicopathological study of large cell neuroendocrine carcinoma and small cell lung carcinoma. Pathol Int 2009;59:522-9.
48. Jones MH, Virtanen C, Honjoh D, et al. Two prognostically significant subtypes of high-grade lung neuroendocrine tumours independent of small-cell and large-cell neuroendocrine carcinomas identified by gene expression profiles. Lancet 2004.;363:775-81. (Pubitemid 38315167)
49. Asamura H, Kameya T, Matsuno Y, et al. Neuroendocrine neoplasms of the lung: a prognostic spectrum. J Clin Oncol 2006;24:70-6. (Pubitemid 46630496)
50. Rusch VW, Klimstra DS, Venkatraman ES. Molecular markers help characterize neuroendocrine lung tumors. Ann Thorac Surg 1996;62:798-809; discussion 809-710.
51. Przygodzki RM, Finkelstein SD, Langer JC, et al. Analysis of p53, K-ras-2, and C-raf-1 in pulmonary neuroendocrine tumors. Correlation with histological subtype and clinical outcome. Am J Pathol 1996;148:1531-41.
52. Varlotto JM, Medford-Davis LN, Recht A, et al. Should large cell neuroendocrine lung carcinoma be classified and treated as a small cell lung cancer or with other large cell carcinomas? J Thorac Oncol 2011;6:1050-8.
53. Bari MF. Biomarkers for the Classification of high grade neuroendocrine lung cancer. Coventry: The University of Warwick, 2013.
54. He P, Varticovski L, Bowman ED, et al. Identification of carboxypeptidase E and gamma-glutamyl hydrolase as biomarkers for pulmonary neuroendocrine tumors by cDNA microarray. Hum Pathol 2004;35:1196-209. (Pubitemid 39361642)
55. Nitadori J, Ishii G, Tsuta K, et al. Immunohistochemical differential diagnosis between large cell neuroendocrine carcinoma and small cell carcinoma by tissue microarray analysis with a large antibody panel. Am J Clin Pathol 2006;125:682-92.
56. Swarts DR, Ramaekers FC, Speel EJ. Molecular and cellular biology of neuroendocrine lung tumors: evidence for separate biological entities. Biochim Biophys Acta 2012;1826:255-71.
57. Dettmer M, Hench J, Pang B, et al. Rhabdoid large cell carcinoma of lung, with illustrative immunohistochemical and molecular findings. Appl Immunohistochem Mol Morphol 2012;20:208-13.
58. Izquierdo-Garcia FM, Moreno-Mata N, Herranz-Aladro ML, et al. Lung carcinoma with rhabdoid component. A series of seven cases associated with uncommon types of non-small cell lung carcinomas and alveolar entrapment. Histol Histopathol 2010.;25:1287-95.
59. Miyagi J, Tsuhako K, Kinjo T, et al. Rhabdoid tumour of the lung is a dedifferentiated phenotype of pulmonary adenocarcinoma. Histopathology 2000;37:37-44. (Pubitemid 30496734)
60. Weissferdt A, Moran CA. Primary pulmonary primitive neuroectodermal tumor (PNET): a clinicopathological and immunohistochemical study of six cases. Lung 2012.;190:677-83.
61. Gu M, Antonescu CR, Guiter G, et al. Cytokeratin immunoreactivity in Ewing's sarcoma: prevalence in 50 cases confirmed by molecular diagnostic studies. Am J Surg Pathol 2000;24:410-16. (Pubitemid 30127477)
62. Koss MN, Hochholzer L, O'Leary T. Pulmonary blastomas. Cancer 1991.;67:2368-81.
63. Weissferdt A, Moran CA. Malignant biphasic tumors of the lungs. Adv Anat Pathol 2011.;18:179-89.
64. Muramatsu T, Shimamura M, Furuichi M, et al. Desmoplastic small round cell tumor of the lung. Ann Thorac Surg 2010;90:e86-87.
65. Ostoros G, Orosz Z, Kovacs G, et al. Desmoplastic small round cell tumour of the pleura: a case report with unusual follow-up. Lung Cancer 2002.;36:333-6. (Pubitemid 34497136)
66. Zhang PJ, Goldblum JR, Pawel BR, et al. Immunophenotype of desmoplastic small round cell tumors as detected in cases with EWS-WT1 gene fusion product. Mod Pathol 2003;16:229-35. (Pubitemid 36337429)
67. Ordonez NG. Desmoplastic small round cell tumor: II: an ultrastructural and immunohistochemical study with emphasis on new immunohistochemical markers. Am J Surg Pathol 1998;22:1314-27. (Pubitemid 28499122)